Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 604 | 547 | 955 | 944 | 2,213 |
| Marketable Securities | 7,743 | 9,443 | 10,238 | 10,537 | 10,733 |
| Receivables | 202 | 306 | 110 | 1,265 | 484 |
| TOTAL | $8,725 | $10,444 | $11,385 | $12,813 | $13,510 |
| Non-Current Assets | |||||
| PPE Net | 281 | 297 | 312 | 318 | 281 |
| Other Non-Current Assets | 26 | 25 | 25 | 23 | 23 |
| TOTAL | $307 | $322 | $337 | $341 | $304 |
| Total Assets | $9,032 | $10,766 | $11,722 | $13,154 | $13,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 699 | 712 | 619 | 630 | 567 |
| Accrued Expenses | 90 | 152 | 576 | 652 | 675 |
| TOTAL | $789 | $864 | $1,195 | $1,282 | $1,242 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $789 | $864 | $1,195 | $1,282 | $1,242 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,250 | 1,246 | 1,246 | 1,244 | 1,244 |
| Common Shares | 11 | 11 | 11 | 11 | 11 |
| Retained earnings | -76,908 | -75,123 | -74,499 | -72,893 | -71,931 |
| TOTAL | $8,243 | $9,902 | $10,527 | $11,872 | $12,572 |
| Total Liabilities And Equity | $9,032 | $10,766 | $11,722 | $13,154 | $13,814 |